IGF2BP2 and breast carcinoma: A recent study demonstrated that IGF2BP2 promoted the degradation of the RNA transcripts of the ATP6V1A gene, thereby impairing lysosomal function and resulting in a unique secretome that greatly enhances breast cancer cell invasiveness 20.